期刊文献+

衰老或肿瘤:癌基因诱导的双向性 被引量:1

Senescence or Tumor:The Dual Role of Activated-oncogene Induction
下载PDF
导出
摘要 在大部分的肿瘤中都发现有癌基因的活化,癌基因的活化被认为是导致肿瘤发生的重要原因.然而,在野生型细胞内,癌基因的活化可以诱导细胞衰老,称为癌基因诱导的细胞衰老(oncogene-induced senescence,OIS),从而抑制进一步的肿瘤发生.因而,癌基因的活化具有诱导衰老或肿瘤的双向性.DNA损伤调控反应(DNA damage checkpoint response,DDR)是细胞应对DNA损伤时感应损伤,从而延迟或阻滞细胞周期进程的一种分子信号传递通路,是诱导细胞衰老的重要机制.癌基因的活化可以引发DNA损伤信号的产生,从而激活DDR,诱导细胞衰老.在DDR异常时,癌基因的激活可引发DNA的过度复制与细胞的过度增殖,并导致基因组不稳定性的积累,最终导致肿瘤发生.DDR的完整性决定了癌基因诱导的双向性.DDR在癌基因诱导中的重要作用,提示了保持和恢复DDR的完整性可以作为肿瘤预防和治疗的新方向. The activation of oncogenes occured in most tumors, and is believed to play an important role in tumorigenesis. However, the activation of oncogenes could induce cellular senescence in wild type cells, known as oncogene-induced senescence (OIS). Thus, the activation of oncogenes has the dual role in inducing cellular senescence or tumorigenesis. DNA damage checkpoint response (DDR) is the molecular signal transduction pathway that delay or arrest cell cycle progression in response to DNA damage and is an important molecular mechanism that induce cellular senescence. Activation of oncogenes could produce DNA damage signals and initiate DDR, which subsequently induce cellular senescence. However, when DDR pathway is deficient, activation of oncogenes could induce unlimited DNA hyper-replication and cellular hyper-proliferation, which results in accumulation of genome instability, and tumorigenesis ultimately. Therefore, the dual role of activated oncogenes is regulated by the integrity of DDR pathway. The key role of DDR in regulating activated oncogenes indicates that maintain or restore the integrity of DDR pathway might provide a new strategy in cancer prevention and therapy.
作者 司晓宇 罗瑛
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2009年第12期1530-1535,共6页 Progress In Biochemistry and Biophysics
基金 国家自然科学基金资助项目(30771194)~~
关键词 癌基因 细胞衰老 癌基因诱导的衰老 DNA损伤调控反应 DNA过度复制 oncogene cellular senescence OIS DDR DNA hyper-replication
  • 相关文献

参考文献29

  • 1Shih C, Weinberg R A. Isolation of a transforming sequence from a human bladder carcinoma cell line. Cell, 1982, 29( 1): 161 - 169.
  • 2Bardeesy N, DePinho R A. Pancreatic cancer biology and genetics. Nat Rev Cancer, 2002, 2(12): 897-909.
  • 3Land H, Parada L F, Weinberg R A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature, 1983,304(5927): 596-602.
  • 4Serrano M, Lin A W, McCurrach M E, et al. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell, 1997, 88(5): 593-602.
  • 5Collado M, Gil J, Efeyan A, et al. Tumour biology: senescence in premalignant tumours. Nature, 2005, 436(7051): 642.
  • 6Michaloglou C, Vredeveld L C, Soengas M S, et al. BRAFE600- associated senescence-like cell cycle arrest of human naevi. Nature, 2005, 436(7051): 720-724.
  • 7Sarkisian C J, Keister B A, Stairs D B, et al. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol, 2007, 9(5): 493-505.
  • 8Mallette F A, Gaumont-Leclerc M F, Ferbeyre G. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev, 2007, 21(1): 43-48.
  • 9Di Micco R, Fumagalli M, Cicalese A, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature, 2006, 444(7119): 638-642.
  • 10Bartkova J, Rezaei N, Liontos M, et al. Oneogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature, 2006, 444(7119): 633 -637.

同被引文献46

  • 1王宝恒,傅玉才,史桂芝,许铭炎,耿义群,徐小虎,许锦阶.LASS1基因克隆及其在大鼠脑皮层的表达与神经元衰老的相关性初步研究(英文)[J].生物化学与生物物理进展,2006,33(8):760-768. 被引量:6
  • 2Robles S J,Adami G R.Agents that cause DNA double strand breaks lead to p16 INK4a enrichment and the premature senescence of normal fibroblasts.Oncogene,1998,16(9):1113-1123.
  • 3Elmore L W,Rehder C W,Di X,et al.Adriamycin-induced senescence in breast tumor cells involves functional p53and telomere dysfunction.J Biol Chem,2002,277(38):35509-35515.
  • 4Kim J H,Kim J H,Lee G E,et al.Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells.Biochem J,2003,373(Pt2):523-529.
  • 5Michaloglou C,Vredeveld L C,Soengas M S,et al.BRAFE600-associated senescence-like cell cycle arrest of human naevi.Nature,2005,436(7051):720-724.
  • 6Rebbaa A,Zheng X,Chou P M,et al.Caspase inhibition switches doxorubicin-induced apoptosis to senescence.Oncogene,2005,22(18):2805-2811.
  • 7Tong Y,Zhao W,Zhou C,et al.PTTG1attenuates drug-induced cellular senescence.PLoS One,2011,6(8):e23754.
  • 8Baker D J,Wijshake T,Tchkonia T,et al.Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders.Nature,2011,479(7372):232-236.
  • 9Von Zglinicki T,Saretzki G,Ladhoff J,et al.Human cell senescence as a DNA damage response.Mech Ageing Dev,2005,126(1):111-117.
  • 10DiLeonardo A,Linke S P,Clarkin K,et al.DNA damage triggers a prolonged p53-dependent G1arrest and long-term induction of Cip1in normal human fibroblasts.Genes Dev,1994,8(21):2540-2551.

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部